References
- Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Gal-Ton D. A.G., Gralnick H., Sultan C., Cox C. The chronic myeloid leukemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group. Brit. J. Haematol. 1994; 87: 746–754
- Kurzrock R., Kantarjian H. M., Shtalrid M., Gutterman J. U., Talpaz M. Philadelphia chromosome-negative chronic myelogenous leukemia without breakpoint cluster region rearrangement: a chronic myeloid leukemia with a distinct clinical course. Blood 1990; 75: 445–452
- Martial P., Michaux J. L., Rodhain J. Philadelphia-negative (Ph-) chronic myeloid leukemia (CML): comparison with Ph+ CML and chronic myelomonocytic leukemia. The Groupe Francais de Cytogenetique Hematologique. Blood 1991; 78: 205–211
- Van Der Plas D. C., Grosveld G., Hagemeijer A. Review of clinical, cytogenetic, and molecular aspects of Ph-negative CML. Cancer Genet. Cytogenet 1991; 52: 143–156
- Costello R., Sainty D., Lafage-Pochitaloff M., Gabert J. Clinical and biological aspects of Philadelphia-negative / BCR-negative chronic myeloid leukemia. Leuk. Lymphoma 1997; 25: 225–232
- Mittelman F. The cytogenetic scenario of chronic myeloid leukemia. Leuk. Lymphoma 1993; 11(1)11–15
- Bain B. Down's syndrome – transient abnormal myelopoiesis and acute leukaemia. Leuk. Lymphoma 1991; 3: 309–317
- Heaton D. C., Fitzgerald P. H., Fraser G. J., Abbott G. D. Transient leukemoid proliferation of the cytogenetically unbalanced +21 cell line of a constitutional mosaic boy. Blood 1981; 57: 883–887
- Hehlmann R., Heimpel H., Kolb H. J., Heinze B., Hochhaus A., Griesshammer M., Pralle H., Queisser W. P., Essres U., Falge C. The German CML study, comparison of busulfan vs hydroxyurea vs interferon alpha and establishment of prognostic score 1. Leuk. Lymphoma 1993; 11(1)159–168
- Groupe Francais de Cytogenetique Hèmatologique. Chronic myelomonocytic leukemia: single entity or heterogeneous disorder? A prospective multicenter study of 100 patients. Cancer Genet. Cytogenet. 1991; 55: 57–65
- Kantarjian H. M., Keating M. J., Walters R. S., McCredie K. B., Smith T. L., Talpaz M., Beran M., Cork A., Trujillo J. M., Freireich E. J. Clinical and prognostic features of Philadelphia chromosome-negative chronic myelogenous leukemia. Cancer 1986; 58: 2023–2030
- Costello R., Lafage M., Toiron Y., Brunei V., Sainty D., Arnoulet C., Mozziconacci M.-J., Bouabdallah R., Gastaut J.-A., Maraninchi D., Gabert L. Philadelphia chromosome-negative chronic myeloid leukaemia: a report of 14 new cases. Brit. J. Haematol. 1995; 90: 346–352
- Michaux J.-L., Martiat P. Chronic myelomonocytic leukaemia (CMML) – a myelodysplasia or myeloproliferative syndrome. Leuk. Lymphoma 1993; 9: 35–41
- Kantarjian H. M., Kurzrock R., Talpaz M. Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia. Oncol. Clin. North Am. 1990; 4: 389–404
- Kurzrock R., Gutterman J. U., Talpaz M. The molecular genetics of Philadelphia chromosome-positive leukemias. New Engl. J. Med. 1988; 319: 990–998